The Benitec / Calimmune gene silencing trial has dosed its first...

The Benitec / Calimmune gene silencing trial has dosed its first patient .

Anyone interested in the HIV space should keep themselves updated .

This modified introduction gene therapy might well work but BIT225 could be a much more cost effective way to eradicate or control the virus .

Regardless of this , the time it will take for both of these ( and any other new approach ) to get through to phase three , is going to be a LONG process .

Meanwhile BIT225 is still first in class .

If big pharma was interested in a cure and not in making obscene amounts of profit from old technologies then we would have a partner for a further HCV trial already . By that I mean we wouldn't be stuffing around with IFN and RBV ..... We would be trialling with newer drugs .

I seems to me the next trial will waste another eighteen months .